News
August Policy Update
Date: 06/23/22
Thank you for your continued partnership with Ambetter. As you know, we continually review and update our payment and utilization policies to ensure that they are designed to comply with industry standards while delivering the best patient experience to our members. We are writing today to inform you of new policies Ambetter will be implementing effective 8/1/2022.
Policy Number | Policy Name | Policy Description | Lines of Business |
|---|---|---|---|
CP.MP.209 | Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing | Restricts reimbursement of GI pathogen panels with 12+ targets to only inpatient settings, including inpatient, ED, and outpatient hospitals. | Marketplace |
For detailed information about these policies, please refer to our website at www.ambettermeridian.com. And for questions about this or any of our payment policies, please don’t hesitate to reach out to our Provider Services team at 833-993-2426.